Literature DB >> 22584947

Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.

Rinku A Tuli1, Graeme A George, Tim R Dargaville, Nazrul Islam.   

Abstract

PURPOSE: To study the effect of the size of the surface-coated polycaprolactone (PCL) microparticle carriers on the aerosolization and dispersion of Salbutamol Sulfate (SS) from Dry Powder Inhaler (DPI) formulations.
METHODS: The microparticles were fabricated using an emulsion technique in four different sizes (25, 48, 104 and 150 μm) and later coated with Magnesium stearate (MgSt) and leucine. They were characterized by laser diffraction and SEM. The Fine Particle Fraction (FPF) of SS from powder mixtures was determined by a Twin Stage Impinger (TSI).
RESULTS: As the carrier size increased from 25 μm to 150 μm, the FPF of the SS delivered by the coated PCL particles increased approximately four fold. A linear relationship was found between the FPF and Volume mean Diameter (VMD) of the particles over this range.
CONCLUSIONS: The dispersion behaviour of SS from PCL carriers was dependent on the inherent size of the carriers and the increased FPF of SS with increased carrier size probably reflects the higher mechanical forces produced due to the carrier-carrier collisions or collisions between the carrier particles and the internal walls of the inhaler during aerosolization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584947     DOI: 10.1007/s11095-012-0772-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect.

Authors:  N M Concessio; M M VanOort; M R Knowles; A J Hickey
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Descriptors of irregular particle morphology and powder properties.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-06-09       Impact factor: 15.470

3.  Deagglomeration of dry powder pharmaceutical aerosols.

Authors:  Austin Voss; Warren H Finlay
Journal:  Int J Pharm       Date:  2002-11-06       Impact factor: 5.875

4.  Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures.

Authors:  Margaret D Louey; Sultana Razia; Peter J Stewart
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

5.  Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.

Authors:  A H de Boer; P Hagedoorn; D Gjaltema; J Goede; H W Frijlink
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

6.  Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation.

Authors:  A H de Boer; P Hagedoorn; D Gjaltema; J Goede; K D Kussendrager; H W Frijlink
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

7.  Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length.

Authors:  Matthew S Coates; David F Fletcher; Hak-Kim Chan; Judy A Raper
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

8.  Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.

Authors:  Martin J Donovan; Hugh D C Smyth
Journal:  Int J Pharm       Date:  2010-09-15       Impact factor: 5.875

9.  The influence of carrier morphology on drug delivery by dry powder inhalers.

Authors:  X M Zeng; G P Martin; C Marriott; J Pritchard
Journal:  Int J Pharm       Date:  2000-04-25       Impact factor: 5.875

10.  Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".

Authors:  P M Young; D Cocconi; P Colombo; R Bettini; R Price; D F Steele; M J Tobyn
Journal:  J Pharm Pharmacol       Date:  2002-10       Impact factor: 3.765

View more
  2 in total

1.  Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.

Authors:  Srinivas R B Behara; Dale R Farkas; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2013-08-16       Impact factor: 4.200

2.  Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery.

Authors:  Md Abdur Rashid; Amged Awad Elgied; Yahya Alhamhoom; Enoch Chan; Llew Rintoul; Ayman Allahham; Nazrul Islam
Journal:  Pharmaceutics       Date:  2019-05-01       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.